Literature DB >> 12667205

X-chromosome-linked immune-deficient mice have B-1b cells.

J Riggs1, K Howell, B Matechin, R Matlack, A Pennello, R Chiasson.   

Abstract

The B lymphocyte subsets of X-chromosome-linked immune-deficient (XID) mice were examined by flow cytometric analyses of spleen and peritoneal cells. As shown in prior studies, young adult XID mice had reduced representation of the CD5+ (B-1a) subset in their peritoneal cavity. However, the CD11b+ (B-1b) B-cell subset was present and exhibited the IgM(hi) CD45(lo) CD23- phenotype characteristic of most B-1 cells. Although present at a lower frequency than that found in their normal counterparts, B-1b cells were evident in CBA/N and (XD2J)F1 male mice. With increasing age, B-1b cell number increased and in the oldest XID mice were present as B-cell chronic lymphocytic leukaemia. These results show that XID mice do have B-1 cells, particularly the B-1b subset.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667205      PMCID: PMC1782925          DOI: 10.1046/j.1365-2567.2003.01624.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  50 in total

1.  Differential development of progenitor activity for three B-cell lineages.

Authors:  A B Kantor; A M Stall; S Adams; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 2.  The development and repertoire of B-1 cells (CD5 B cells).

Authors:  A B Kantor
Journal:  Immunol Today       Date:  1991-11

3.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

4.  Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation.

Authors:  C G Vinuesa; Y Sunners; J Pongracz; J Ball; K M Toellner; D Taylor; I C MacLennan; M C Cook
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

5.  Are xid B lymphocytes representative of any normal B cell population. A commentary.

Authors:  D E Mosier
Journal:  J Mol Cell Immunol       Date:  1985

6.  Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence.

Authors:  R R Hardy; K Hayakawa; D R Parks; L A Herzenberg
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

7.  Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals.

Authors:  A M Stall; M C Fariñas; D M Tarlinton; P A Lalor; L A Herzenberg; S Strober; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 8.  B-cell subsets defined by the Fc epsilon R.

Authors:  T Waldschmidt; K Snapp; T Foy; L Tygrett; C Carpenter
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

9.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

10.  Co-expression of Mac-1 and p150,95 on CD5+ B cells. Structural and functional characterization in a human chronic lymphocytic leukemia.

Authors:  A De la Hera; M Alvarez-Mon; F Sanchez-Madrid; C Martinez; A Durantez
Journal:  Eur J Immunol       Date:  1988-07       Impact factor: 5.532

View more
  8 in total

1.  Induction of in vivo antipolysaccharide immunoglobulin responses to intact Streptococcus pneumoniae is more heavily dependent on Btk-mediated B-cell receptor signaling than antiprotein responses.

Authors:  Abdul Q Khan; Goutam Sen; Shuling Guo; Owen N Witte; Clifford M Snapper
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

2.  CD19 expression in B cells is important for suppression of contact hypersensitivity.

Authors:  Rei Watanabe; Manabu Fujimoto; Nobuko Ishiura; Yoshihiro Kuwano; Hiroko Nakashima; Norihito Yazawa; Hitoshi Okochi; Shinichi Sato; Thomas F Tedder; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

3.  B-1 cells are pivotal for in vivo inflammatory giant cell formation.

Authors:  Cristina Stewart Bittencourt Bogsan; Ronni Rômulo Novaes e Brito; Maiko da Cruz Palos; Renato Arruda Mortara; Sandro Rogério Almeida; José Daniel Lopes; Mario Mariano
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

4.  Interleukin-10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Andre Kipnis; Marcela Henao Tamayo; Marisa Harton; Mercedes Gonzalez Juarrero; Randall J Basaraba; Ian M Orme
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

5.  Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro.

Authors:  Ana Flavia Popi; José Daniel Lopes; Mario Mariano
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

6.  Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.

Authors:  Jamee C Nixon; Scott Ferrell; Cathrine Miner; Athenia L Oldham; Ute Hochgeschwender; Carol F Webb
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 7.  Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity.

Authors:  Alexander N R Weber; Zsofia Bittner; Xiao Liu; Truong-Minh Dang; Markus Philipp Radsak; Cornelia Brunner
Journal:  Front Immunol       Date:  2017-11-08       Impact factor: 7.561

8.  Crucial Role of Increased Arid3a at the Pre-B and Immature B Cell Stages for B1a Cell Generation.

Authors:  Kyoko Hayakawa; Yue-Sheng Li; Susan A Shinton; Srinivasa R Bandi; Anthony M Formica; Joni Brill-Dashoff; Richard R Hardy
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.